Contemporary outcomes from renal mass biopsy series
| Series | Cases | Accuracy (%) | Complications (%) | |||
|---|---|---|---|---|---|---|
| Diagnosis | Malignancy | RCC subtype | Grade | |||
| Veltri et al.61 | 103 | 100 | NA | 93.2 | NA | 5.3 |
| Dechet et al.63 | 100 | 100 | 76 | NA | NA | NA |
| Richter et al.64 | 205 | 62.4 | 38.3 | NA | NA | NA |
| Lebret et al.59 | 119 | 79 | 86 | 86 | 74* | 0 |
| Maturen et al.45 | 152 | 96 | Sensitivity 97.7; specificity 100 | NA | NA | 1.3 |
| Shannon et al.44 | 235 | 78 | 100 | 98 | NA | 0.9 |
| Volpe et al.49 | 100 | 84 | 100 | 100 | 75* | 1.0 |
| Leveridge et al.9 | 345 | 80.6 | 99.7 | 88 | 63.5 | 0.3 |
| Veltri et al.61 | 150 | 100 | NA | 93.2 | NR | 0 |
| Wang et al.51 | 110 | 90.9 | 100 | 96.6 | NR | 1.8 |
RCC, renal cell carcinoma; *, classified as low (Fuhrman grade I/II) or high (Fuhrman grade III/IV). Restricted to series with at least 100 biopsies performed for brevity.